I and B Minister Prakash Javadekar condemns alleged attack on Arnab Goswami

New Delhi, Jun 4: India on Thursday witnessed a record single-day spike of 9,304 coronavirus cases taking the country's tally to 2,16,919, according to the Union Ministry of Health and Family Welfare.

The ministry informed that 260 more deaths due to coronavirus were reported in the last 24 hours.

The total number of cases in the country now stands at 2,16,919 including 1,06,737 active cases, 1,04,107 cured/discharged/migrated and 6,075 deaths.

Maharashtra has so far reported 74,860 cases, more than any other state in the country.

In Tamil Nadu, 25,872 cases have been detected so far while Delhi has reported 23,645 coronavirus cases.

According to the Indian Council of Medical Research (ICMR), 1,39,485 samples were tested in the last 24 hours whereas 42,42,718 samples have been tested till date.

Gwalior, Jul 23: As India's daily infections of coronavirus keep rising, the country is fighting a pandemic which is getting bigger by the day.

A vaccine, according to the World Health Organization, may not be coming until early 2021 despite good progress on the font. There is also, so far, no definitive cure for the virus, yet.

Madhya Pradesh Assembly Protem Speaker and Bharatiya Janata Party(BJP) leader Rameshwar Sharma, however, feels that the end of the coronavirus pandemic will begin with the start of the construction work for Ram Temple in Ayodhya.

"He (Lord Ram) had reincarnated for the welfare of mankind and to kill demons at that time. As soon as the construction of Ram Temple begins the destruction of the COVID pandemic will begin too," said Sharma, reports ANI.

"Not only India, but the entire world is suffering due to coronavirus. We are not only maintaining social distancing but also remembering our holy figures. The Supreme Court has ordered that Ram Temple will be built," he further added.

The treasurer of Shri Ram Janmabhoomi Tirtha Kshetra Trust, Swami Govind Dev Giri had said that Prime Minister Narendra Modi will lay the foundation stone of Ram Temple on August 5.

He said that social-distancing norms would be ensured at the program, and not more than 200 people will be attending the ceremony.

"The Prime Minister will visit Hanuman Garhi, Ram Lalla Temple, plant a tree and later do the 'bhoomi pujan'," he told ANI.

Ram Mandir trust spokesperson Nritya Gopal Das said five silver bricks will be placed inside the sanctum sanctorum during the ceremony.

The bricks are believed to symbolise five planets as per the Hindu mythology, he said, adding that the design and the architecture of the temple is the same as the one proposed.

According to the trust sources, Home Minister Amit Shah, Defence Minister Rajnath Singh, RSS chief Mohan Bhagwat , Maharashtra Chief Minister Udhav Thackeray and Bihar CM Nitish Kumar are also on the list of invitees.

India so far has recorded 1.19 million coronavirus positive cases, and 28,732 deaths.

Bengaluru, Apr 30: Shares of Glenmark Pharmaceuticals Ltd rose almost 9% on Thursday after the Indian drugmaker got an approval to conduct clinical trials with antiviral drug favipiravir, seen as a potential treatment for COVID-19.

Favipiravir, manufactured under the brand name Avigan by a unit of Japan's Fujifilm Holdings Corp and approved for use as an anti-flu drug in the Asian island country in 2014, has been effective, with no obvious side-effects, in helping coronavirus patients recover, a Chinese official told reporters at a news conference last month.

"After having successfully developed the API and the formulations ... Glenmark is all geared to immediately begin clinical trials on favipiravir on COVID-19 patients in India," Sushrut Kulkarni, executive vice-president for Global R&D, Glenmark Pharmaceuticals, said in a statement. 

The Drug Controller General of India, the country's drug regulator, did not immediately respond to Reuters request for comment.

On Wednesday, another Indian pharmaceutical company, Strides Pharma Science Ltd, said it had developed and commercialized favipiravir antiviral tablets, and had applied to Indian drug authorities to start trials.

Shares of Mumbai-based Glenmark Pharmaceuticals, which rose as much as 8.9% to 359 rupees ($4.78), was trading up 5.9%, as of 0407 GMT.